Annual EBIT:
$279.17M+$777.25M(+156.05%)Summary
- As of today, SRPT annual earnings before interest & taxes is $279.17 million, with the most recent change of +$777.25 million (+156.05%) on December 31, 2024.
- During the last 3 years, SRPT annual EBIT has risen by +$634.59 million (+178.54%).
- SRPT annual EBIT is now at all-time high.
Performance
SRPT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$62.88M-$178.46M(-154.40%)Summary
- As of today, SRPT quarterly earnings before interest & taxes is -$62.88 million, with the most recent change of -$178.46 million (-154.40%) on September 30, 2025.
- Over the past year, SRPT quarterly EBIT has dropped by -$85.08 million (-383.29%).
- SRPT quarterly EBIT is now -138.89% below its all-time high of $161.68 million, reached on December 31, 2024.
Performance
SRPT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$86.01M-$85.08M(-9128.22%)Summary
- As of today, SRPT TTM earnings before interest & taxes is -$86.01 million, with the most recent change of -$85.08 million (-9128.22%) on September 30, 2025.
- Over the past year, SRPT TTM EBIT has dropped by -$167.03 million (-206.15%).
- SRPT TTM EBIT is now -139.44% below its all-time high of $218.08 million, reached on December 31, 2024.
Performance
SRPT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SRPT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +156.1% | -383.3% | -206.2% |
| 3Y3 Years | +178.5% | +52.1% | +83.9% |
| 5Y5 Years | +140.9% | +54.1% | +86.0% |
SRPT EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +143.8% | -138.9% | +79.1% | -139.4% | +85.4% |
| 5Y | 5-Year | at high | +140.9% | -138.9% | +79.1% | -139.4% | +86.1% |
| All-Time | All-Time | at high | +140.9% | -138.9% | +79.1% | -139.4% | +86.1% |
SRPT EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$62.88M(-154.4%) | -$86.01M(-9128.2%) |
| Jun 2025 | - | $115.58M(+138.5%) | -$932.00K(+99.2%) |
| Mar 2025 | - | -$300.39M(-285.8%) | -$117.21M(-153.7%) |
| Dec 2024 | $279.17M(+156.0%) | $161.68M(+628.4%) | $218.08M(+169.2%) |
| Sep 2024 | - | $22.20M(+3266.3%) | $81.03M(+113.3%) |
| Jun 2024 | - | -$701.00K(-102.0%) | $37.99M(+140.1%) |
| Mar 2024 | - | $34.91M(+41.7%) | -$94.83M(+64.6%) |
| Dec 2023 | -$498.09M(+21.8%) | $24.63M(+218.2%) | -$267.82M(+32.9%) |
| Sep 2023 | - | -$20.84M(+84.4%) | -$399.28M(+21.7%) |
| Jun 2023 | - | -$133.52M(+3.3%) | -$509.80M(+13.2%) |
| Mar 2023 | - | -$138.09M(-29.3%) | -$587.41M(-9.5%) |
| Dec 2022 | -$636.72M(-79.1%) | -$106.83M(+18.7%) | -$536.20M(-0.2%) |
| Sep 2022 | - | -$131.35M(+37.8%) | -$535.18M(-22.1%) |
| Jun 2022 | - | -$211.13M(-143.0%) | -$438.28M(-11.0%) |
| Mar 2022 | - | -$86.88M(+17.9%) | -$394.73M(+12.2%) |
| Dec 2021 | -$355.42M(+27.9%) | -$105.81M(-207.1%) | -$449.71M(+12.6%) |
| Sep 2021 | - | -$34.46M(+79.4%) | -$514.51M(+16.6%) |
| Jun 2021 | - | -$167.57M(-18.1%) | -$617.12M(-5.0%) |
| Mar 2021 | - | -$141.87M(+16.9%) | -$587.90M(-4.2%) |
| Dec 2020 | -$493.12M(+27.8%) | -$170.62M(-24.5%) | -$564.06M(+8.1%) |
| Sep 2020 | - | -$137.07M(+0.9%) | -$613.47M(-2.2%) |
| Jun 2020 | - | -$138.35M(-17.2%) | -$599.99M(-6.4%) |
| Mar 2020 | - | -$118.03M(+46.4%) | -$563.76M(-8.0%) |
| Dec 2019 | -$683.21M(-107.7%) | -$220.02M(-78.0%) | -$522.12M(-19.3%) |
| Sep 2019 | - | -$123.59M(-21.0%) | -$437.67M(-13.9%) |
| Jun 2019 | - | -$102.13M(-33.7%) | -$384.18M(+0.9%) |
| Mar 2019 | - | -$76.39M(+43.7%) | -$387.70M(-13.3%) |
| Dec 2018 | -$328.90M(-668.0%) | -$135.56M(-93.4%) | -$342.05M(-49.1%) |
| Sep 2018 | - | -$70.10M(+33.6%) | -$229.39M(-27.7%) |
| Jun 2018 | - | -$105.65M(-243.7%) | -$179.59M(-39.6%) |
| Mar 2018 | - | -$30.74M(-34.2%) | -$128.63M(+6.0%) |
| Dec 2017 | -$42.83M(+83.9%) | -$22.90M(-12.8%) | -$136.90M(+32.4%) |
| Sep 2017 | - | -$20.31M(+62.9%) | -$202.39M(+14.7%) |
| Jun 2017 | - | -$54.68M(-40.2%) | -$237.35M(+2.8%) |
| Mar 2017 | - | -$39.01M(+55.9%) | -$244.15M(+7.6%) |
| Dec 2016 | -$265.37M(-21.4%) | -$88.39M(-59.9%) | -$264.31M(-10.0%) |
| Sep 2016 | - | -$55.27M(+10.1%) | -$240.36M(-1.5%) |
| Jun 2016 | - | -$61.47M(-3.9%) | -$236.86M(-8.9%) |
| Mar 2016 | - | -$59.17M(+8.2%) | -$217.49M(-3.1%) |
| Dec 2015 | -$218.66M(-63.4%) | -$64.45M(-24.5%) | -$210.90M(-10.3%) |
| Sep 2015 | - | -$51.76M(-22.9%) | -$191.17M(-10.5%) |
| Jun 2015 | - | -$42.11M(+19.9%) | -$173.08M(-7.3%) |
| Mar 2015 | - | -$52.58M(-17.6%) | -$161.24M(-21.1%) |
| Dec 2014 | -$133.79M(-48.2%) | -$44.72M(-32.8%) | -$133.19M(-9.9%) |
| Sep 2014 | - | -$33.67M(-11.2%) | -$121.22M(-7.8%) |
| Jun 2014 | - | -$30.27M(-23.4%) | -$112.42M(-13.3%) |
| Mar 2014 | - | -$24.52M(+25.1%) | -$99.23M(-10.7%) |
| Dec 2013 | -$90.28M(-204.0%) | -$32.75M(-31.6%) | -$89.67M(-33.3%) |
| Sep 2013 | - | -$24.88M(-45.6%) | -$67.28M(-36.4%) |
| Jun 2013 | - | -$17.09M(-14.3%) | -$49.31M(-30.5%) |
| Mar 2013 | - | -$14.95M(-44.3%) | -$37.78M(-27.2%) |
| Dec 2012 | -$29.70M(+17.3%) | -$10.37M(-50.1%) | -$29.70M(-9.2%) |
| Sep 2012 | - | -$6.91M(-24.3%) | -$27.19M(+13.8%) |
| Jun 2012 | - | -$5.56M(+19.2%) | -$31.56M(+12.6%) |
| Mar 2012 | - | -$6.87M(+12.5%) | -$36.13M(-3.9%) |
| Dec 2011 | -$35.93M | -$7.86M(+30.3%) | -$34.78M(-21.4%) |
| Sep 2011 | - | -$11.27M(-11.3%) | -$28.66M(-37.9%) |
| Jun 2011 | - | -$10.13M(-83.1%) | -$20.79M(-33.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$5.53M(-218.8%) | -$15.53M(+12.4%) |
| Dec 2010 | -$20.93M(-35.0%) | -$1.74M(+48.9%) | -$17.73M(+11.1%) |
| Sep 2010 | - | -$3.40M(+30.2%) | -$19.95M(-2.4%) |
| Jun 2010 | - | -$4.87M(+37.1%) | -$19.48M(+1.0%) |
| Mar 2010 | - | -$7.74M(-95.6%) | -$19.68M(-26.9%) |
| Dec 2009 | -$15.51M(+11.6%) | -$3.95M(-35.2%) | -$15.51M(-7.3%) |
| Sep 2009 | - | -$2.92M(+42.3%) | -$14.45M(+11.9%) |
| Jun 2009 | - | -$5.07M(-42.1%) | -$16.40M(-1.2%) |
| Mar 2009 | - | -$3.56M(-23.2%) | -$16.22M(+1.6%) |
| Dec 2008 | -$17.54M(+47.0%) | -$2.89M(+40.7%) | -$16.48M(+14.4%) |
| Sep 2008 | - | -$4.88M(0.0%) | -$19.26M(+15.9%) |
| Jun 2008 | - | -$4.88M(-27.3%) | -$22.89M(+14.8%) |
| Mar 2008 | - | -$3.83M(+32.4%) | -$26.85M(+20.2%) |
| Dec 2007 | -$33.11M(-0.4%) | -$5.67M(+33.4%) | -$33.64M(+8.4%) |
| Sep 2007 | - | -$8.51M(+3.7%) | -$36.75M(-3.5%) |
| Jun 2007 | - | -$8.84M(+16.8%) | -$35.51M(-4.2%) |
| Mar 2007 | - | -$10.62M(-21.1%) | -$34.09M(-3.3%) |
| Dec 2006 | -$32.98M(-88.3%) | -$8.77M(-20.6%) | -$32.98M(-13.3%) |
| Sep 2006 | - | -$7.27M(+2.0%) | -$29.12M(-22.5%) |
| Jun 2006 | - | -$7.42M(+22.1%) | -$23.76M(-10.6%) |
| Mar 2006 | - | -$9.52M(-94.1%) | -$21.49M(-22.7%) |
| Dec 2005 | -$17.52M(+30.1%) | -$4.91M(-155.8%) | -$17.52M(+0.2%) |
| Sep 2005 | - | -$1.92M(+62.8%) | -$17.55M(+15.4%) |
| Jun 2005 | - | -$5.15M(+7.2%) | -$20.75M(+9.1%) |
| Mar 2005 | - | -$5.55M(-12.3%) | -$22.84M(+8.8%) |
| Dec 2004 | -$25.04M(-32.7%) | -$4.94M(+3.6%) | -$25.04M(+8.1%) |
| Sep 2004 | - | -$5.12M(+29.2%) | -$27.27M(-1.7%) |
| Jun 2004 | - | -$7.23M(+6.7%) | -$26.82M(-15.9%) |
| Mar 2004 | - | -$7.75M(-8.3%) | -$23.14M(-22.6%) |
| Dec 2003 | -$18.87M(+25.5%) | -$7.16M(-53.0%) | -$18.87M(-18.9%) |
| Sep 2003 | - | -$4.68M(-31.7%) | -$15.87M(+4.2%) |
| Jun 2003 | - | -$3.55M(-2.1%) | -$16.56M(+20.9%) |
| Mar 2003 | - | -$3.48M(+16.2%) | -$20.93M(+17.4%) |
| Dec 2002 | -$25.34M(-64.5%) | -$4.15M(+22.7%) | -$25.34M(+1.8%) |
| Sep 2002 | - | -$5.37M(+32.2%) | -$25.79M(-8.5%) |
| Jun 2002 | - | -$7.92M(-0.3%) | -$23.77M(-21.1%) |
| Mar 2002 | - | -$7.90M(-71.5%) | -$19.63M(-28.5%) |
| Dec 2001 | -$15.40M(-50.4%) | -$4.60M(-37.6%) | -$15.28M(-11.7%) |
| Sep 2001 | - | -$3.35M(+11.6%) | -$13.68M(-5.8%) |
| Jun 2001 | - | -$3.78M(-6.9%) | -$12.92M(-6.9%) |
| Mar 2001 | - | -$3.54M(-17.7%) | -$12.10M(-23.5%) |
| Dec 2000 | -$10.24M(-23.4%) | -$3.01M(-16.1%) | -$9.80M(-44.3%) |
| Sep 2000 | - | -$2.59M(+12.3%) | -$6.79M(-5.4%) |
| Jun 2000 | - | -$2.96M(-138.2%) | -$6.44M(-16.4%) |
| Mar 2000 | - | -$1.24M(>-9900.0%) | -$5.53M(+9.4%) |
| Dec 1999 | -$8.30M(-6.4%) | $0.00(+100.0%) | -$6.10M(0.0%) |
| Sep 1999 | - | -$2.24M(-9.4%) | -$6.10M(-5.7%) |
| Jun 1999 | - | -$2.05M(-12.8%) | -$5.77M(-4.4%) |
| Mar 1999 | - | -$1.82M(>-9900.0%) | -$5.53M(-4.2%) |
| Dec 1998 | -$7.80M(-100.0%) | $0.00(+100.0%) | -$5.31M(+15.8%) |
| Sep 1998 | - | -$1.91M(-6.0%) | -$6.31M(-19.1%) |
| Jun 1998 | - | -$1.80M(-13.0%) | -$5.30M(-12.8%) |
| Mar 1998 | - | -$1.60M(-59.6%) | -$4.70M(-26.9%) |
| Dec 1997 | -$3.90M(-77.3%) | -$1.00M(-11.1%) | -$3.70M(-37.0%) |
| Sep 1997 | - | -$900.00K(+25.0%) | -$2.70M(-50.0%) |
| Jun 1997 | - | -$1.20M(-100.0%) | -$1.80M(-200.0%) |
| Mar 1997 | - | -$600.00K | -$600.00K |
| Dec 1996 | -$2.20M | - | - |
FAQ
- What is Sarepta Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. annual EBIT year-on-year change?
- What is Sarepta Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Sarepta Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. TTM EBIT year-on-year change?
What is Sarepta Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of SRPT is $279.17M
What is the all-time high annual EBIT for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high annual earnings before interest & taxes is $279.17M
What is Sarepta Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, SRPT annual earnings before interest & taxes has changed by +$777.25M (+156.05%)
What is Sarepta Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of SRPT is -$62.88M
What is the all-time high quarterly EBIT for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $161.68M
What is Sarepta Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, SRPT quarterly earnings before interest & taxes has changed by -$85.08M (-383.29%)
What is Sarepta Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of SRPT is -$86.01M
What is the all-time high TTM EBIT for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $218.08M
What is Sarepta Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, SRPT TTM earnings before interest & taxes has changed by -$167.03M (-206.15%)